Expression of vascular endothelial growth factor in human umbilical vein endothelial cells stimulated with interleukin-1alpha--an autocrine regulation of angiogenesis and inflammatory reactions
- PMID: 10896254
Expression of vascular endothelial growth factor in human umbilical vein endothelial cells stimulated with interleukin-1alpha--an autocrine regulation of angiogenesis and inflammatory reactions
Abstract
Vascular endothelial growth factor (VEGF) is a specific mitogen for endothelial cells. We studied the production of VEGF by human umbilical vein endothelial cells (HUVEC) and smooth muscle cells (SMC) in response to the stimulation with interleukin-1alpha (IL-1alpha). HUVEC expressed VEGF mRNA in response to IL-1alpha in dose- and time-dependent manners. In HUVEC VEGF protein was detected only in cell lysates whereas in SMC most of the VEGF protein was detected in the conditioned medium. Immunofluorescent staining also confirmed the cell-associated VEGF in HUVEC. IL-1alpha also induced the expression of mRNA for IL-1alpha itself in HUVEC. Cycloheximide treatment of HUVEC slightly inhibited the IL-1alpha-induced expression of VEGF mRNA, and IL-1alpha may mediate, at least in part, VEGF expression in response to IL-1alpha. The growth of HUVEC stimulated with IL-1alpha was inhibited by a neutralizing antibody against VEGF. We conclude that IL-1alpha and VEGF may play an important role in autocrine growth regulation of HUVEC.
Similar articles
-
Interleukin-1alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion.FASEB J. 2002 Sep;16(11):1471-3. doi: 10.1096/fj.02-0134fje. Epub 2002 Jul 18. FASEB J. 2002. PMID: 12205052
-
Triptolide inhibits vascular endothelial growth factor expression and production in endothelial cells.Acta Pharmacol Sin. 2001 Jul;22(7):651-6. Acta Pharmacol Sin. 2001. PMID: 11749832
-
Vascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients: regulation by cytokines and bacterial lipopolysaccharide.Hepatology. 1999 Apr;29(4):1057-63. doi: 10.1002/hep.510290416. Hepatology. 1999. PMID: 10094946
-
Vascular smooth muscle contractility assays for inflammatory and immunological mediators.Int Immunopharmacol. 2010 Nov;10(11):1344-53. doi: 10.1016/j.intimp.2010.08.016. Epub 2010 Sep 8. Int Immunopharmacol. 2010. PMID: 20831918 Review.
-
Hypoxia and endothelial-smooth muscle cell interactions in the lung.Am J Respir Cell Mol Biol. 1994 Oct;11(4):373-4. doi: 10.1165/ajrcmb.11.4.7917305. Am J Respir Cell Mol Biol. 1994. PMID: 7917305 Review. No abstract available.
Cited by
-
Anti-bevacizumab idiotype antibody vaccination is effective in inducing vascular endothelial growth factor-binding response, impairing tumor outgrowth.Cancer Sci. 2016 Apr;107(4):551-5. doi: 10.1111/cas.12903. Cancer Sci. 2016. PMID: 27079440 Free PMC article.
-
Hybrid cardiovascular sourced extracellular matrix scaffolds as possible platforms for vascular tissue engineering.J Biomed Mater Res B Appl Biomater. 2020 Apr;108(3):910-924. doi: 10.1002/jbm.b.34444. Epub 2019 Aug 1. J Biomed Mater Res B Appl Biomater. 2020. PMID: 31369699 Free PMC article.
-
Constitutive phosphorylation of the mTORC2/Akt/4E-BP1 pathway in newly derived canine hemangiosarcoma cell lines.BMC Vet Res. 2012 Jul 29;8:128. doi: 10.1186/1746-6148-8-128. BMC Vet Res. 2012. PMID: 22839755 Free PMC article.
-
Endothelial-to-Mesenchymal Transition in Human Adipose Tissue Vasculature Alters the Particulate Secretome and Induces Endothelial Dysfunction.Arterioscler Thromb Vasc Biol. 2019 Oct;39(10):2168-2191. doi: 10.1161/ATVBAHA.119.312826. Epub 2019 Aug 22. Arterioscler Thromb Vasc Biol. 2019. PMID: 31434495 Free PMC article.
-
Antiangiogenic therapy in human gastrointestinal malignancies.Gut. 2006 Oct;55(10):1497-511. doi: 10.1136/gut.2005.088229. Gut. 2006. PMID: 16966704 Free PMC article. Review. No abstract available.